Thermo Fisher Scientific Inc. (NYSE:TMO) Announces Quarterly Dividend of $0.47

Thermo Fisher Scientific Inc. (NYSE:TMO) declared a quarterly dividend on Wednesday, February 25th. Investors of record on Friday, March 13th will be paid a dividend of 0.47 per share by the medical research company on Wednesday, April 15th. This represents a c) dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Friday, March 13th. This is a 9.3% increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.43.

Thermo Fisher Scientific has increased its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend annually for the last 8 consecutive years. Thermo Fisher Scientific has a payout ratio of 7.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Thermo Fisher Scientific to earn $25.56 per share next year, which means the company should continue to be able to cover its $1.72 annual dividend with an expected future payout ratio of 6.7%.

Thermo Fisher Scientific Trading Down 0.2%

NYSE TMO traded down $1.21 during trading hours on Thursday, hitting $512.47. 414,711 shares of the company’s stock were exchanged, compared to its average volume of 2,547,178. Thermo Fisher Scientific has a 1-year low of $385.46 and a 1-year high of $643.99. The company has a current ratio of 1.89, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The stock has a 50-day simple moving average of $576.02 and a 200 day simple moving average of $547.25. The firm has a market cap of $192.54 billion, a price-to-earnings ratio of 28.90, a PEG ratio of 2.97 and a beta of 0.93.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Thursday, January 29th. The medical research company reported $6.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.45 by $0.12. The business had revenue of $12.22 billion for the quarter, compared to analyst estimates of $11.95 billion. Thermo Fisher Scientific had a net margin of 15.05% and a return on equity of 16.92%. Thermo Fisher Scientific’s revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the firm earned $6.10 earnings per share. On average, equities analysts forecast that Thermo Fisher Scientific will post 23.28 EPS for the current fiscal year.

Thermo Fisher Scientific announced that its board has initiated a share repurchase program on Thursday, November 6th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the medical research company to reacquire up to 2.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its stock is undervalued.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.